Trial intelligence / Profile preview

PSD502 in Premature Ejaculation

NCT00556478Phase 3Completed

Sponsor
Plethora Solutions
Start
Oct 2007
Primary completion
Oct 2009
Modality
Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

A Phase 3 trial of Fortacin in premature ejaculation (PE), sponsored by Plethora Solutions. Started Oct 2007; status: completed.

02

Drugs

Fortacin
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on NCT00556478.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00556478.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call